IBRUTINIB-INDUCED CHRONIC DEMYELINATING POLYNEUROPATHY IN A 65-YEAR-OLD MAN WITH CHRONIC LYMPHOID LEUCOSIS: A CLINICAL CASE
Relevance. Most of oncological patients undergo chemotherapy, which has a wide range of various toxic reactions including polyneuropathy. Ibrutinib is a relatively new medicine with a few side effects associated with peripheral polyneuropathy. Demyelinating polyneuropathy induced by this drug is not...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Amaltea Medical Publishing House
2018-03-01
|
| Series: | Romanian Journal of Neurology |
| Subjects: | |
| Online Access: | http://revistemedicale.amaltea.ro/Romanian_Journal_of_NEUROLOGY/Revista_Romana_de_NEUROLOGIE-2018-Nr.1/RJN_2018_1_Art-08.pdf |